Author Archive: Abigail Hirsch

Abigail Hirsch

Abigail is the Director of Events Communications at BIO. Although she has lived in the Washington, DC, area for nearly eight years, she still considers Virginia Beach home, especially with her parents and closest friends still in the area. According to Abigail, there is nothing better than sitting on the beach with a good book and cold drink. In her spare time, she enjoys visiting antique stores, finishing her twin sister Brooke’s sentences and spending time with her two boys, Frank her English bulldog, and JP her soon-to-be husband. Check back often for updates, Abigail’s take on BIO related events, and much more. And please, be kind, this is her first venture in to the blogging world!

Latest Posts

BIO Investor Forum – Raring to Go: The Race to Treat Ultra-Rare Diseases

BIO Investor Forum

The signing of FDASIA by President Obama in July reinforces the country’s commitment to fostering innovation for rare diseases. With a record 460 medicines in late-stage clinical trials, biopharmaceutical companies have embraced rare disease medicine and are rapidly developing the pipeline. In anticipation of an even more compelling opportunity, many companies are taking a step beyond and focusing on ultra rare diseases. Last week’s 11th Annual BIO Investor Forum in San Francisco hosted a panel, Raring Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

BIO Travels to Brazil to Support the Ecosystem of Innovation

Refinery

Government policies that support innovation are critical as the biotechnology industry seeks to develop innovative healthcare, agricultural, industrial and environmental biotechnology products and provide them to people all around the world. Innovation requires not only scientific research and commercial expertise, but also supportive and dynamic governments that help facilitate long-term growth of the industry. Brazil has recognized the value of innovation in maintaining a robust, diversified economy that can compete in the 21st century, and declared Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

2012 BIO Technology Transfer Symposium

tt-symp

BIO’s Technology Transfer Symposium is right around the corner, next Monday, October 8th in fact. And whether you are planning on attending the BIO Investor Forum, the Tech Transfer offers a unique insight in to the value of biotech public-private partnerships. The Tech Transfer highlights recent and successful early stage technology transfer deals from a variety of perspectives, including universities, government and venture capitalists. Attendees will learn about how technology transfer offices and industry are working Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

2012 BIO Investor Forum: Presenting Companies Making News

san-fran

Need a heart valve? Perhaps a bit more cartilage in your knees? Better yet, how about new blood vessels to bypass the old blocked ones? Amazingly, the days of relying upon animal or human cadavers’ tissue grafts to address these medical needs may possibly be drawing to a close. This is not Star Trek and this is not the Walt Disney’s optimistic science of Tomorrowland. As detailed in the Wall Street Journal last week, medical Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO India Hosts Biopharmaceutical Regulatory and Policy Roundtable

bio-india-btn

During last week’s BIO India International Conference, BIO, in partnership with the Association of Biotech-Led Enterprises (ABLE) and the Confederation of Indian Industries (CII) held a roundtable to discuss ways that U.S. and Indian industry can work together to facilitate the development of new biotechnology products and commercialization. Participants in the roundtable represented U.S. and Indian industry, academia, and government and shared their views on critical issues important to the development of the Indian biotechnology Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,